Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis-Reference-Cited by-同舟云学术

Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis

Published:2023-02 Issue: Volume:76 Page:101769
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Dwabe Sami,Hsiao Mindy,Ali Amir,Rodman Jack,Savitala-Damerla Lakshmi,Nazaretyan Samvel,Kimberly Schiff N.P.,Tam Eric,Ladha Abdulla,Woan Karrune,Chaudhary Preet,Yaghmour George

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference21 articles.

1. Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification;Dziedzic;Anticancer Res.,2017

2. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation;Marty;N. Engl. J. Med.,2017

3. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation;Broers;Blood.,2000

4. Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors;Meijer;Clin. Infect. Dis.,2002

5. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review;El Helou;Infect Drug Resist.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study;Journal of Infection;2024-08

2. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management. A report from the CMV International Symposium 2023;Transplant Infectious Disease;2023-11-09

3. Isolation, synthesis and identification of degraded impurities in Letermovir;Journal of Pharmaceutical and Biomedical Analysis;2023-11

4. Cytomegalovirus resistance in transplant patients Review;Global Journal of Clinical Virology;2023-10-19

5. Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: A narrative review;Journal of Medical Virology;2023-08